Scarica l'app Stockscreener
6.33
3.21%
-0.21
Dopo l'orario di chiusura:
6.04
-0.29
-4.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AURA Giù?
Forum
Previsione
Precedente Chiudi:
$6.54
Aprire:
$6.57
Volume 24 ore:
180.35K
Relative Volume:
0.71
Capitalizzazione di mercato:
$401.98M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-3.2969
EPS:
-1.92
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
-1.09%
1M Prestazione:
+14.47%
6M Prestazione:
-1.40%
1 anno Prestazione:
-24.73%
Intervallo 1D:
$6.24
$6.635
Intervallo di 1 settimana:
$6.24
$6.69
Portata 52W:
$4.345
$9.04
Aura Biosciences Inc Stock (AURA) Company Profile
Nome
Aura Biosciences Inc
Settore
Industria
Telefono
(617)500-8864
Indirizzo
80 GUEST STREET, BOSTON
Confronta AURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.33 | 415.31M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-26 | Ripresa | Evercore ISI | Outperform |
| 2025-05-28 | Ripresa | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-07-19 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Aura Biosciences Inc Borsa (AURA) Ultime notizie
Aura Biosciences, Inc. $AURA Stock Position Increased by B Group Inc. - Defense World
(AURA) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Rally Mode: Why Aura Biosciences Inc stock is trending among retail tradersEarnings Performance Report & Capital Efficiency Focused Strategies - moha.gov.vn
Weekly Recap: Will BWMN stock beat EPS estimatesQuarterly Profit Review & Momentum Based Trading Ideas - BỘ NỘI VỤ
Why Aura Biosciences Inc. stock is trending among retail tradersWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Can Aura Biosciences Inc. stock outperform in 2025 bull marketWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Aura Biosciences (AURA) Stock Analysis Report | Financials & Insights - Benzinga
Aura Biosciences re-initiated with an Outperform at Evercore ISI - MSN
Market Pulse: Can Aura Biosciences Inc. stock continue upward trendPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn
Evercore ISI Group Reiterates Aura Biosciences (AURA) Outperform Recommendation - MSN
What drives Aura Biosciences Inc stock priceStock Buyback Announcements & Double Or Triple Wealth - earlytimes.in
Avenzo adds CFO responsibilities to CBO Lipman’s role - BioCentury
(AURA) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
AURA Stock Receives an "Outperform" Rating from Evercore ISI Gro - GuruFocus
Is Aura Biosciences (NASDAQ:AURA) In A Good Position To Deliver On Growth Plans? - Sahm
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating By Investing.com - Investing.com Canada
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences - TipRanks
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Aura Biosciences (NASDAQ: AURA) CEO Fireside Chat at Evercore Healthcare Conf. 2025 - Stock Titan
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
How Aura Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Review & Weekly High Potential Alerts - newser.com
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Canada
Is Aura Biosciences Inc. stock attractive for growth ETFsEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Leerink Partnrs Has Positive Outlook of AURA FY2025 Earnings - Defense World
Aura Biosciences Inc. stock trend forecastJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Aura Biosciences Inc. stock outlook for YEARBuy Signal & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Aura Biosciences Inc. stockGap Down & Weekly Market Pulse Updates - newser.com
Is it time to cut losses on Aura Biosciences Inc.2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
Why Aura Biosciences Inc. stock could see breakout soonPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Top Executive Makes Bold Move with Aura Biosciences Stock Sale! - TipRanks
Officer Hopkins Files To Sell 17,109 Of Aura Biosciences Inc [AURA] - TradingView
Aura Biosciences CMO Sells Shares to Cover Tax Obligations - TradingView
Officer Hopkins Surrenders 17,109 Of Aura Biosciences Inc [AURA] - TradingView
[Form 4] Aura Biosciences, Inc. Insider Trading Activity - Stock Titan
What is HC Wainwright’s Estimate for AURA Q1 Earnings? - Defense World
Volume spikes in Aura Biosciences Inc. stock – what they meanQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-11-16 12:54:55 - newser.com
Using fundamentals and technicals on Aura Biosciences Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
How Aura Biosciences Inc. stock performs in weak economyJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
(AURA) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Aura Biosciences Inc Azioni (AURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):